# Iter Investments

Iter Investments is a Private Equity based in Fort Lauderdale, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Fort Lauderdale, United States
- **Region:** North America
- **Address:** Fort Lauderdale, FL, United States
- **Founded:** 2020
- **Assets under management:** Undisclosed
- **Website:** iterinvestments.com
- **LinkedIn:** https://www.linkedin.com/company/iter-investments

## Regulatory record

- **Reports private funds:** No

## About

Iter Investments is a venture capital firm focused on supporting emerging companies developing alternative therapeutics for behavioral and mental health. The firm invests in and supports breakthrough companies in the alternative therapeutics industry to revolutionize mental and behavioral health. Its team includes builders, investors, lawyers, scientists, physicians, clinicians, and technologists fueling entrepreneurs impacting global mental health and well-being.

## Sectors

- Psychedelic Medicine
- Digital Health
- Mental Health & Wellness

## People

- Dustin Robinson — Esq. CPA, Founder
- Robert Velarde — Founder
- Dr. Michelle Weiner — DO MPH, Clinical Lead
- Dr. Scott Fisher — MD, Psychiatric Lead
- Edgar Asebey — Esq, FDA Lead
- John M.H. Gregg — MBA, CLP, Commercialization Lead
- David Wood — Esq. PhD, Intellectual Property Lead
- Rayyan Zafar — Research Lead
- Andrew Hall — PHD, Scientific Lead
- Matt Savarick — Tech Lead
- Amanda Barton — Legal Advisor
- Samuel Baum — Marketing Lead

## Questions

### What is Iter Investments' specific investment focus?

Iter Investments is a venture capital firm exclusively focused on the psychedelic medicine and mental health sector. The firm invests in early-stage companies across the value chain, including drug discovery platforms, clinical research organizations, and the clinic networks that administer psychedelic-assisted therapies.

### Which portfolio companies have been publicly linked to Iter Investments?

Publicly disclosed portfolio positions include atai Life Sciences, a clinical-stage biopharmaceutical platform developing multiple psychedelic compounds. The firm also targets specialized treatment-clinic operators and drug-discovery ventures, though the full portfolio is not publicly detailed.

### What jurisdictions does Iter Investments focus on?

Iter Investments deploys capital primarily in North America and Europe. These regions have the most advanced regulatory frameworks for psychedelic-assisted therapies, which reduces binary legal risk for the clinic networks and drug developers the firm backs.

## Related profiles

- [Iterative](https://altss.com/profile/iterative)
- [IT-Farm](https://altss.com/profile/it-farm)

---

Last updated: 2026-08-11T15:07:05.535Z

Canonical page: https://altss.com/profile/iter-investments

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology